• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Australia·Healthcare·HIQ.AX
Share

HITIQ Limited Stocks

A$ 0Last Updated 20.10.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

A$ 3.22M

A$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

HITIQ Limited is an Australian enterprise focused on developing and commercializing advanced technology for concussion management. Its Nexus software platform delivers comprehensive data and analytical insights concerning head impacts, empowering informed decision-making to enhance care for athletes. The company also offers CoVR, a virtual reality-based system for assessing cognitive and oculomotor functions, capable of identifying impairments in areas such as hand-eye coordination, memory, and critical thinking. Additionally, CSX provides a straightforward sideline tool for concussion evaluation, generating digital records that can be easily shared with medical professionals, family members, and organizations to ensure coordinated athlete support. Established in 2015, the company maintains its headquarters in Melbourne, Australia.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 21:10

Shares of Ray-Ban had their best day since 2008. Should you buy them?

21.10.2026 20:20

The Old World on New Chips: How Nvidia Is Driving the Industrial Revolution in Europe

21.10.2026 20:13

Getty Images has filed for bankruptcy. It will become privately owned.

21.10.2026 19:00

SpaceX's strong results boosted U.S. stocks. Is the worst behind us?

21.10.2026 18:30

"The Music's Still Playing": What Wall Street Recommends Doing with Meta Shares Ahead of the Earnings Report

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026